Norcross A - Search Results

Year	Number of Results
1990	1
1997	1
2001	2
2003	1
2004	2
2006	2
2008	1
2009	1
2010	2
2011	3
2025	0

1

Lack of a clinically meaningful pharmacokinetic effect of rifabutin on raltegravir: in vitro/in vivo correlation.

Brainard DM, Kassahun K, Wenning LA, Petry AS, Liu C, Lunceford J, Hariparsad N, Eisenhandler R, Norcross A, DeNoia EP, Stone JA, Wagner JA, Iwamoto M. Brainard DM, et al. Among authors: norcross a. J Clin Pharmacol. 2011 Jun;51(6):943-50. doi: 10.1177/0091270010375959. Epub 2010 Sep 17. J Clin Pharmacol. 2011. PMID: 20852006 Clinical Trial.

2

CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonist.

Tang C, Carr BA, Poignant F, Ma B, Polsky-Fisher SL, Kuo Y, Strong-Basalyga K, Norcross A, Richards K, Eisenhandler R, Carlini EJ, Di Marco CN, Kuduk SD, Yu NX, Raab CE, Rushmore T, Frederick CB, Bock MG, Prueksaritanont T. Tang C, et al. Among authors: norcross a. J Pharmacol Exp Ther. 2008 Jun;325(3):935-46. doi: 10.1124/jpet.107.136044. Epub 2008 Feb 29. J Pharmacol Exp Ther. 2008. PMID: 18310472

3

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.

Gale EA, Bingley PJ, Emmett CL, Collier T; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Gale EA, et al. Lancet. 2004 Mar 20;363(9413):925-31. doi: 10.1016/S0140-6736(04)15786-3. Lancet. 2004. PMID: 15043959 Clinical Trial.

4

Killing, abortion, and contraception: a reply to Marquis.

Norcross A. Norcross A. J Philos. 1990 May;87(5):268-77. J Philos. 1990. PMID: 11782097 No abstract available.

5

Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization.

Aicher L, Meier G, Norcross AJ, Jakubowski J, Varela MC, Cordier A, Steiner S. Aicher L, et al. Among authors: norcross aj. Biochem Pharmacol. 1997 Mar 7;53(5):723-31. doi: 10.1016/s0006-2952(96)00772-1. Biochem Pharmacol. 1997. PMID: 9113092

6

Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamine.

Williams AJ, Norcross AJ, Chandler KA, Bingley PJ. Williams AJ, et al. Among authors: norcross aj. J Immunol Methods. 2006 Jul 31;314(1-2):170-3. doi: 10.1016/j.jim.2006.06.003. Epub 2006 Jun 28. J Immunol Methods. 2006. PMID: 16843481

7

Effects of hyperbaric oxygen therapy on an accelerated rate of mandibular distraction osteogenesis.

Salgado CJ, Raju A, Licata L, Patel M, Rojavin Y, Wasielewski S, Diarra C, Gordon A, Norcross A, Kent KA. Salgado CJ, et al. Among authors: norcross a. J Plast Reconstr Aesthet Surg. 2009 Dec;62(12):1568-72. doi: 10.1016/j.bjps.2008.06.071. Epub 2009 Feb 5. J Plast Reconstr Aesthet Surg. 2009. PMID: 19200793

8

Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial.

Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, Jackson N, Fitzsimons K, Bright J, Coulman K, England CY, Gorton J, McLenaghan A, Paxton E, Polet A, Thompson C, Dayan CM. Andrews RC, et al. Among authors: norcross aj. Lancet. 2011 Jul 9;378(9786):129-39. doi: 10.1016/S0140-6736(11)60442-X. Epub 2011 Jun 24. Lancet. 2011. PMID: 21705068 Free article. Clinical Trial.

9

The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.

Williams AJ, Norcross AJ, Lock RJ, Unsworth DJ, Gale EA, Bingley PJ. Williams AJ, et al. Among authors: norcross aj. Diabetes Care. 2001 Mar;24(3):504-9. doi: 10.2337/diacare.24.3.504. Diabetes Care. 2001. PMID: 11289476

10

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.

Bingley PJ, Gale EA; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Bingley PJ, et al. Diabetologia. 2006 May;49(5):881-90. doi: 10.1007/s00125-006-0160-4. Epub 2006 Mar 3. Diabetologia. 2006. PMID: 16514546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year